Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 1.00 |
| ▸ | KLK7 | P49862 | 1/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.83 |
| ▸ | PPARG | P37231 | 2/20 | 0.79 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 9/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.69 |
| ▸ | MEN1 | O00255 | 6/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.69 |
| ▸ | TP53 | P04637 | 5/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.69 |
| ▸ | HPGD | P15428 | 3/20 | 0.69 |
| ▸ | MAOA | P21397 | 2/20 | 0.69 |
| ▸ | MAOB | P27338 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29448332 | 0.95 | RAB9A (0.90) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| Glycitein SCHEMBL6578666 | 0.92 | RAB9A (0.85) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| Glycitein SCHEMBL29497281 | 0.91 | HDAC6 (1.00) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| Glycitein SCHEMBL19720 | 0.91 | HDAC6 (1.00) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| Glycitein SCHEMBL7733712 | 0.91 | HDAC6 (1.00) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| Formonetin SCHEMBL4728656 | 0.91 | RAB9A (0.83) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| SCHEMBL7030328 | 0.89 | RAB9A (0.81) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| SCHEMBL30573375 | 0.89 | RAB9A (0.81) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| SCHEMBL5423281 | 0.89 | RAB9A (0.80) | RAB9AKLK7HDAC6PPARGPTPN1 | |
| Odoratin SCHEMBL1248967 | 0.88 | PTPN1 (1.00) | RAB9AKLK7HDAC6PPARGPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4583856-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | Native Code Bio, LLC (US) | 2025-07-16 | — | — | EP | claimed |
| WO-2024054688-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO, LLC (US) | 2024-03-14 | — | — | WO | claimed |
| CN-114642695-A | Big data traditional Chinese medicine composition for regulating and controlling prostate cancer | 华子昂 | 2022-06-21 | — | — | CN | claimed |
| CN-104822424-A | Oral compositions for enhancing skin tolerance following topical application of retinoid compounds | INNEOV LAB | 2015-08-05 | — | — | CN | claimed |
| CN-104661692-A | Balloon surface coating for valvuloplasty | CARDIONOVUM GMBH | 2015-05-27 | — | — | CN | claimed |
| CN-104394898-A | Balloon surface coating | CARDIONOVUM GMBH | 2015-03-04 | — | — | CN | claimed |
| CN-103702654-A | Use of a combination of a carotenoid, a phytoestrogen and vitamin C for the prevention and/or treatment of pigmentation disorders | INNEOV LAB | 2014-04-02 | — | — | CN | claimed |
| CN-103596548-A | Combination of carotenoids, phytoestrogens and vitamin C for skin moisturization | INNEOV LAB | 2014-02-19 | — | — | CN | claimed |
| CN-101636187-B | Biodegradable vascular support | HEMOTEQ AG | 2013-08-28 | — | — | CN | claimed |
| CN-103025362-A | Coating of endoprostheses with a coating consisting of a tight mesh of polymer fibres | HEMOTEQ AG | 2013-04-03 | — | — | CN | claimed |
| CN-101636187-A | Biodegradable vascular support | HEMOTEQ GMBH | 2010-01-27 | — | — | CN | claimed |
| JP-2067218-A | — | — | None | — | — | JP | disclosed |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4665318-A2 | THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS | Native Code Bio, LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4583856-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | Native Code Bio, LLC (US) | 2025-07-16 | — | — | EP | disclosed |
| EP-0027796-A4 | CHROMAN AND CHROMANON-4 DERIVATIVES, PROCESS FOR THEIR PREPARATION, ANTIOXIDANT COMPOSITIONS CONTAINING SAME AND THEIR USE FOR STABILIZING EDIBLE FATS AND OILS. | Z L LTD PARTNERSHIP (US) | 1981-08-31 | — | — | EP | disclosed |
| EP-0027796-A1 | CHROMAN AND CHROMANON-4 DERIVATIVES, PROCESS FOR THEIR PREPARATION, ANTIOXIDANT COMPOSITIONS CONTAINING SAME AND THEIR USE FOR STABILIZING EDIBLE FATS AND OILS. | Z L LTD PARTNERSHIP (US) | 1981-05-06 | — | — | EP | disclosed |
| US-4264509-A | STORAGE STABILITY FOR FOODS CONTAINING OILS AND FATS | Z-L LIMITED PARTNERSHIP (US) | 1981-04-28 | — | — | US | disclosed |
| WO-1980002098-A1 | ISOFLAVONES AND RELATED COMPOUNDS,METHODS OF PREPARING AND USING AND ANTIOXIDANT COMPOSITIONS CONTAINING SAME | PARTNERSHIP LTD (US) | 1980-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | HMBS, SNCA, PYGB | RAB9A 459/4885KLK7 4682/4885HDAC6 4058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.